168 related articles for article (PubMed ID: 37622528)
1. Identifying Predictors of Treatment Response in Meniere's Disease: A Clinical Severity Staging System.
Miller BJ; Kallogjeri D; Shew MA; Piccirillo JF
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):212-220. PubMed ID: 37622528
[TBL] [Abstract][Full Text] [Related]
2. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
3. Intratympanic corticosteroids for Ménière's disease.
Webster KE; Lee A; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Westerberg B; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015245. PubMed ID: 36847608
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic gentamicin for Ménière's disease.
Webster KE; Galbraith K; Lee A; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015246. PubMed ID: 36847592
[TBL] [Abstract][Full Text] [Related]
5. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
[TBL] [Abstract][Full Text] [Related]
7. Positive pressure therapy for Ménière's disease or syndrome.
van Sonsbeek S; Pullens B; van Benthem PP
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD008419. PubMed ID: 25756795
[TBL] [Abstract][Full Text] [Related]
8. Recent surgical advances and continued controversies in medically refractory Meniere's disease.
Lucas JC; Hong RS
Curr Opin Otolaryngol Head Neck Surg; 2023 Oct; 31(5):325-331. PubMed ID: 37266594
[TBL] [Abstract][Full Text] [Related]
9. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
[TBL] [Abstract][Full Text] [Related]
11. Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.
Silverstein H; Wazen J; Van Ess MJ; Daugherty J; Alameda YA
Otolaryngol Head Neck Surg; 2010 Apr; 142(4):570-5. PubMed ID: 20304280
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Intratympanic Gentamicin in Menière's Disease With and Without Migraine.
Liu YF; Renk E; Rauch SD; Xu HX
Otol Neurotol; 2017 Aug; 38(7):1005-1009. PubMed ID: 28538472
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic gentamicin therapy for Ménière's disease.
Hirsch BE; Kamerer DB
Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
[TBL] [Abstract][Full Text] [Related]
14. Systemic pharmacological interventions for Ménière's disease.
Webster KE; Galbraith K; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015171. PubMed ID: 36827524
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies.
Phillips J; Mikulec AA; Robinson JM; Skarinsky D; Anderson JJ
Otol Neurotol; 2023 Jul; 44(6):584-592. PubMed ID: 37185596
[TBL] [Abstract][Full Text] [Related]
16. Intratympanic gentamicin for intractable Meniere's disease.
Perez N; Martín E; García-Tapia R
Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of the Meniett device in Ménière's disease: the Western Australian experience.
Rajan GP; Din S; Atlas MD
J Laryngol Otol; 2005 May; 119(5):391-5. PubMed ID: 15949105
[TBL] [Abstract][Full Text] [Related]
18. Surgical interventions for Ménière's disease.
Lee A; Webster KE; George B; Harrington-Benton NA; Judd O; Kaski D; Maarsingh OR; MacKeith S; Ray J; Van Vugt VA; Burton MJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD015249. PubMed ID: 36825750
[TBL] [Abstract][Full Text] [Related]
19. Familial clustering of migraine, episodic vertigo, and Ménière's disease.
Cha YH; Kane MJ; Baloh RW
Otol Neurotol; 2008 Jan; 29(1):93-6. PubMed ID: 18046258
[TBL] [Abstract][Full Text] [Related]
20. Comparison of second-echelon treatments for Ménière's disease.
Basura GJ; Lin GC; Telian SA
JAMA Otolaryngol Head Neck Surg; 2014 Aug; 140(8):754-61. PubMed ID: 25057891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
